In this episode, we have Dr. Dudley Lamming, PhD, Associate Professor and Researcher at the Department of Medicine, Endocrinology at the University of Wisconsin-Madison. We will talk about aging and specifically about a molecule that has been gaining interest in the scientific field: mTOR. We’ll discuss its importance, how it is regulated, and much more. Additionally, we will explore the effects of Rapamycin and its potential pharmacological applications. Join us for an insightful discussion! Dr. Lamming’s research focuses on understanding how nutrient-responsive signaling pathways can be harnessed to promote health and longevity.
Follow me on social media:
Instagram: https://www.instagram.com/doctoref.rain/
Facebook: https://www.facebook.com/efrain.riverosperez
Reference: Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nat Aging. 2023 Jun;3(6):642-660. doi: 10.1038/s43587-023-00416-y. Epub 2023 May 4. PMID: 37142830; PMCID: PMC10330278.
Disclosure:
The content of this podcast is purely academic in nature and is intended for educational and informational purposes only. The material discussed does not represent or reflect the views, opinions, or policies of the Medical College of Georgia, and the information presented should not be construed as medical advice or guidance. Always consult with a qualified healthcare professional for any medical concerns or questions. I'd like to explicitly state that I have no endorsement from, affiliations with, or financial interests in any pharmaceutical companies or medical device manufacturers. Any mention of medications, devices, or treatments is made solely within the context of literature and academic discussion.
